Drugs / Myo-inositol

Trials 26

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04204044 Nov 2020 → May 2021 polycystic ovary syndrome Rashid Latif Medical College Unknown No outcome recorded
Phase 11 trial
Phase 1 NCT07459595 May → Jul 2026 overdue polycystic ovary syndrome Fatima Tariq Not yet recruiting No outcome recorded
Phase 22 trials
Phase 2 NCT07635082 Feb 2024 → Jun 2025 polycystic ovary syndrome Eman Basuni Ebrahim Mowad Completed No outcome recorded
Phase 2 NCT00349726 Jun 2006 → Dec 2007 bronchopulmonary dysplasia, fetal growth restriction, retinopathy of prematurity NICHD Neonatal Research Network Completed No outcome recorded
Phase 2/33 trials
Phase 2/3 NCT05900661 Jul → Sep 2023 — Beni-Suef University Unknown No outcome recorded
Phase 2/3 NCT04273256 Feb 2020 → Feb 2022 ovarian dysfunction American University of Beirut Medical Center Unknown No outcome recorded
Phase 2/3 NCT03201601 Feb 2016 → May 2017 infertility disorder, polycystic ovary syndrome Biosearch S.A. Completed No outcome recorded
Phase 35 trials · 2 met primary
Phase 3 NCT07323589 Jan → Jul 2025 polycystic ovary syndrome PAEC general hospital Completed Met primary
Phase 3 NCT06405204 Jun → Dec 2024 — Beni-Suef University Unknown Met primary
Phase 3 NCT06405243 Jun → Dec 2024 polycystic ovary syndrome Beni-Suef University Unknown No outcome recorded
Phase 3 NCT03767569 Sep 2018 → Apr 2020 female infertility, polycystic ovary syndrome University Hospital Brussels Unknown No outcome recorded
Phase 3 NCT01954082 Apr 2014 → Dec 2016 retinopathy of prematurity NICHD Neonatal Research Network Terminated No outcome recorded
Phase 44 trials
Phase 4 NCT07701525 Jun → Nov 2025 polycystic ovary syndrome Nishtar Medical University Completed No outcome recorded
Phase 4 NCT04306692 Jul 2020 → Apr 2021 female infertility, polycystic ovary syndrome University Hospital, Ghent Terminated No outcome recorded
Phase 4 NCT03177122 Mar 2017 → Dec 2023 female infertility American University of Beirut Medical Center Unknown No outcome recorded
Phase 4 NCT01511822 — polycystic ovary syndrome AGUNCO Obstetrics and Gynecology Centre Completed No outcome recorded
Phase not applicable10 trials
— NCT07629895 Sep 2026 → Apr 2027 expected polycystic ovary syndrome Quaid-e-Azam Medical College Not yet recruiting No outcome recorded
— NCT07604779 May → Dec 2026 expected polycystic ovary syndrome Beni-Suef University Active not recruiting No outcome recorded
— NCT07266259 Sep 2025 → Aug 2026 overdue polycystic ovary syndrome Mst.Sumyara Khatun Recruiting No outcome recorded
— NCT07380841 May → Nov 2025 metabolic syndrome X, polycystic ovary syndrome Islamabad Medical and Dental College Completed No outcome recorded
— NCT07387679 Nov 2024 → May 2025 polycystic ovary syndrome Muhammad Aamir Latif Completed No outcome recorded
— NCT05767515 Jul 2023 → Feb 2024 female infertility, polycystic ovary syndrome Khyber Medical University Peshawar Completed No outcome recorded
— NCT05951309 Sep 2021 → Sep 2022 polycystic ovary syndrome Near East University, Turkey Completed No outcome recorded
— NCT05943158 Jun 2021 → Jun 2022 pregnancy disorder Near East University, Turkey Completed No outcome recorded
— NCT04892186 Mar 2021 → Oct 2023 glucose intolerance, polycystic ovary syndrome University of Sao Paulo General Hospital Completed No outcome recorded
— NCT02651636 Jun 2014 → Jul 2015 menstrual disorder, polycystic ovary syndrome Catholic University of the Sacred Heart Completed No outcome recorded
Comparator or background therapy11 trials
Phase 1 NCT06170463 Comparator Aug 2022 → Mar 2023 polycystic ovary syndrome Zagazig University Completed No outcome recorded
Phase 1/2 NCT03153436 Comparator Aug 2016 → Apr 2017 — Sohag University Completed No outcome recorded
Phase 2 NCT04867252 Comparator May → Aug 2021 polycystic ovary syndrome Khyber Medical University Peshawar Completed No outcome recorded
Phase 2 NCT02633462 Comparator May 2015 → Oct 2016 periodontitis, polycystic ovary syndrome Postgraduate Institute of Dental Sciences Rohtak Unknown No outcome recorded
Phase 2/3 NCT07585396 Comparator Apr 2024 → Jun 2026 infertility disorder, polycystic ovary syndrome Kafrelsheikh University Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 37 sources stand behind the page.

FieldValueCited text
Known as Myo-inositol “This group is given myoinositol+d-chiro inositol+folic acid once a day (inofolic combi, ITF company, Italy) (myoinositol 550 miligram+ d-chiroinositol 13,8 miligram+folic acid...” NCT05951309 ↗
39

“Myo-inositol 2 g orally twice daily (4 g/day) for 8 weeks as metabolic priming, followed by letrozole 7.5 mg/day orally on cycle days 3-7 for three consecutive cycles.” NCT07585396 ↗

“Myo-inositol (MI) is one of the most important of the 9 inositol stereoisomers, and this molecule has been studied many times in the literature in recent years.” NCT05943158 ↗

“Participants allocated to this arm will receive myo-inositol 2 g orally twice daily for a duration of 3 months prior to ovulation induction.” NCT07635082 ↗

“The promising role of two of its isomers namely Myo-inositol (MI) and D-chiro-inositol (DCI) in the treatment of PCOS has been documented.” NCT05767515 ↗

“The objective of this study is to compare the outcome of Metformin versus Myo-inositol in the management of polycystic ovarian disease.” NCT07459595 ↗

“Myo-Inositol is a carbocyclic sugar, belongs to Inositol group and is an important component of structural lipids.” NCT04867252 ↗

“Myo-inositol (MI) protects against MAFLD through reduction of hepatic accumulation of triglycerides.” NCT06170463 ↗

“60 mg/kg (1.2ml/kg) of myo-inositol 5% given intravenously over 20 minutes.” NCT00349726 ↗

“Levocarnitine 330 mg and Myoinositol 750 mg twice daily for 3 months” NCT07266259 ↗

NCT05900661 ↗

Show 29 more sources

Known as MYO “myoinositol/d-chiro-inositol combination (MYO/DCI) in 40:1 ratiotwice daily” NCT07058675 ↗
Modality Small molecule “Myo-Inositol is a carbocyclic sugar, belongs to Inositol group” NCT04867252 ↗
Route Intravenous “given intravenously over 20 minutes.” NCT00349726 ↗